본문 바로가기
KERD
논문KCI 등재

경피적 관상동맥중재술 후 재협착 예방에 대한 한약의 효과 : 무작위배정 대조군 임상연구에 대한 체계적 문헌고찰 및 메타분석

Effect of Herbal Medicines on Preventing Restenosis After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis of Randomized Controlled Trials

김홍준|장인수|허나연|안수빈
대한한방내과학회 (The Society Of Korean Oriental Internal Medicine)|2023.06|대한한방내과학회지 (The Journal of Korean Oriental Internal Medicine)|제44권 제3호|pp. 387-401

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

meta-analysissystematic reviewherbal medicinerestenosispercutaneous coronary interventionoronary artery disease
주제분류한의학

초록

Objective: This study was conducted to investigate the preventive effect of herbal medicines on restenosis after percutaneous coronary intervention (PCI) by reviewing randomized controlled trials (RCTs). Methods: RCTs were searched for herbal medicine treatment after PCI using eight online databases (PubMed, CNKI, Wanfang, J-STAGE, OASIS, ScienceON, KTKP, and KISS). Studies that confirmed restenosis through coronary angiography at follow-up were selected according to the inclusion and exclusion criteria. The primary outcome was the restenosis rate, and the secondary outcome was the angina recurrence rate. Data were extracted from the final selected studies according to the research methodology and then analyzed with Review Manager 5.4.1. Study quality was assessed using Cochrane’s risk-of-bias (RoB) tool. Results: Of the 252 papers obtained through the primary search, nine studies that met the selection criteria were finally selected. In these nine studies, herbal medicine combined with western medicine was used for the experimental group, and western medicine treatment was used alone for the control group. The meta-analysis result revealed that the restenosis rate and angina recurrence rate were significantly lower in the experimental group than in the control group (RR=0.34, 95% CI: 0.22-0.53, p<0.00001, I²=0% and RR=0.47, 95% CI: 0.29-0.78, p=0.004, I²=0%, respectively). Furthermore, the quality of studies assessed by Cochrane’s RoB was low. Conclusions: This study showed that the combined treatment of herbal medicine and western medicine was effective in preventing restenosis and angina after PCI. As the number of papers included in this study was small, a large number of high-quality clinical studies should be considered in the future.

Abstract

Objective: This study was conducted to investigate the preventive effect of herbal medicines on restenosis after percutaneous coronary intervention (PCI) by reviewing randomized controlled trials (RCTs). Methods: RCTs were searched for herbal medicine treatment after PCI using eight online databases (PubMed, CNKI, Wanfang, J-STAGE, OASIS, ScienceON, KTKP, and KISS). Studies that confirmed restenosis through coronary angiography at follow-up were selected according to the inclusion and exclusion criteria. The primary outcome was the restenosis rate, and the secondary outcome was the angina recurrence rate. Data were extracted from the final selected studies according to the research methodology and then analyzed with Review Manager 5.4.1. Study quality was assessed using Cochrane’s risk-of-bias (RoB) tool. Results: Of the 252 papers obtained through the primary search, nine studies that met the selection criteria were finally selected. In these nine studies, herbal medicine combined with western medicine was used for the experimental group, and western medicine treatment was used alone for the control group. The meta-analysis result revealed that the restenosis rate and angina recurrence rate were significantly lower in the experimental group than in the control group (RR=0.34, 95% CI: 0.22-0.53, p<0.00001, I²=0% and RR=0.47, 95% CI: 0.29-0.78, p=0.004, I²=0%, respectively). Furthermore, the quality of studies assessed by Cochrane’s RoB was low. Conclusions: This study showed that the combined treatment of herbal medicine and western medicine was effective in preventing restenosis and angina after PCI. As the number of papers included in this study was small, a large number of high-quality clinical studies should be considered in the future.

참고문헌 (38)

  1. Sasaki S, "Cardiovascular and neurological medicine in Korean medicine Ⅱ", pp.134~147 (2016), Woori medical books
  2. 2021 annual report on the causes of deaths statistics, "Statistics Korea", Statistics Korea, ~ (2021)
  3. Roth GA, "Global burden of cardiovascular diseases and risk factors, 1990-2019 : Update from the GBD 2019Study", J Am Coll Cardiol, 76(25), pp.2982~3021 (2020)
  4. Ang YX, "Non-invasive treatment for coronary in-stent restenosis via wireless revascularization with nitinol active Stent", IEEE Trans Biomed Eng, 68(12), pp.3681~3689 (2021)
  5. Lawton JS, "2021ACC", AHA, american heart association joint committee on clinical practice guidelines, pp.Circulation, 2022[DOI]
  6. Lansky A, "Paclitaxelcoated balloons : a safe alternative to drug-eluting stents for coronary in-stent restenosis", Eur Heart J, 41(38), pp.3729~3731 (2020)
  7. Iakovou I, "Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents", JAMA, 293(17), pp.2126~2130 (2005)
  8. Rosand J, "The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage", Arch Intern Med, 164(8), pp.880~884 (2004)
  9. 배서은, "항혈소판제 단독 혹은 병합요법이 상부위장관 출혈에 미치는 영향", 대한소화기학회지, 57(4), pp.213~220 (2011), 대한소화기학회
  10. 송성환, "세계 전통의학 동향과 주요 한의학 R&D 분야에 관한 연구", 한국한의학연구원논문집, 16(1), pp.101~109 (2010), 한국한의학연구원
  11. 민선우, "경피적관상동맥중재술을 시행한 후 발생한 胸痛에 대한 한방치료 1례", 대한한방내과학회지, 42(2), pp.184~196 (2021), 대한한방내과학회[DOI]
  12. Hui J, "Efficacy and safety of different courses of Tongxinluo capsule as adjuvant therapy for coronary heart disease after percutaneous coronary intervention : a systematic review and metaanalysis of randomized controlled trials", J Clin Med, 11(11), pp.2991~ (2022)
  13. Xu G, "Meta-analysis of the clinical efficacy and safety of Xiongshao capsule in the treatment of in-stent restenosis after PCI", Chin J Integr Med Cardio, 2022, pp.20(22), 4045~4051
  14. Chen Y, "Evaluating the advantages of traditional Chinese medicine for supplementing qi and promoting blood circulation method in the prevention and treatment of ISR after PCI based on meta-analysis", Chin J Integr Med Cardio, 2022, pp.20(14), 2497~2507
  15. Du Y, "Meta-analysis on efficacy of yiqi huoxue Chinese drugs in the treatment of coronary heart disease after coronary revascularization", Medicinal Plant, 10(03), pp.69~76 (2019)
  16. Luo X, "Meta-analysis of clinical effect of combined phlegm-eliminating and blood-stasis-removing herbs on restenosis after PCI", Guiding J Tradit Chin Med Pharmacol, 26(11), pp.131~137 (2020)
  17. Ren Y, "Systematic review of randomized controlled trials on preventing and treating restenosis after percutaneous coronary intervention with Chinese medicine", Chin J Integr Med, 07, pp.597~601 (2008)
  18. Wu J, "Chinese herbal medicines for restenosis after percutaneous coronary intervention : a meta-analysis of randomized controlled trials", J Altern Complement Med, 25(10), pp.983~992 (2019)
  19. Liu S, "Application effect of Tongxinluo capsule combined with clopidogrel and aspirin in patients with coronary heart disease after PCI", Clin Res Pract, 4(19), pp.127~131 (2019)
  20. Zhou X, "Clinical observation of Gualou Xiebai granule in the treatment of PCI postoperative restenosis in soft plaque of coronary artery with syndrome of phlegm-dampness blocking", Shanghai J Tradit Chin Med, 51(11), pp.41~44 (2017)
  21. Hu X, "Clinical observation of Yan ’s Wenyang Huoxue recipe in the prevention and treatment of restenosis after percutaneous coronary intervention", Shanghai J Tradit Chin Med, 51(04), pp.59~62 (2017)
  22. Liu L, "The influence of Tongxinluo capsule and atorvastatin on in-stent restenosis and inflammatory factors after percutaneous coronary intervention", Chin J Integr Med Cardio, 2017, pp.15(07), 769~771
  23. Wang K, "Clinical effect of Huxinkang tablets in treatment of restenosis after percutaneous coronary interventionin patients with coronary heart disease", Hunan J Tradit Chin Med, 32(12), pp.7~9 (2016)
  24. Sun Q, "Efficacy of integrated traditional Chinese and western medicine in prevention of restenosis after percutaneous coronary intervention", J New Chin Medicine, 48(02), pp.31~33 (2016)
  25. Tang M, "Effects of prostaglandin E1 combined with Tongxinluo capsule on PCI inflammatory factor and restenosis", J Hunan Univ Chin Med, 35(06), pp.54~56 (2015)
  26. Niu X, "41 Cases of restenosis in patients with coronary heart disease after PCI with Jingqi Danshen Yin", J Tradit Chin Med, 53(17), pp.1503~1504 (2012)
  27. Cheng S, "Effect of Anxin granule on the restenosis after percutaneous coronary intervention", J Tradit Chin Med, 51(07), pp.603~606 (2010)
  28. Kim SY, "NECA’s guidance for undertaking systematic reviews and meta-analyses for intervention", National evidence-based healthcare collaborating agency, 65~70 (2011)
  29. 김우종, "큰 관상동맥 병변에서 약물방출스텐트와 금속스텐트의 임상경과 비교", 대한내과학회지, 80(6), pp.664~671 (2011), 대한내과학회
  30. Kim MS, "In-stent restenosis", Cardiovasc Ther, 29(3), pp.190~198 (2011)
  31. 김영상, "심뇌혈관질환 예방을 위한 아스피린의 근거중심 사용법", Korean Journal of Family Medicine, 30(4), pp.249~260 (2009), 대한가정의학회
  32. Sasaki S, "Cardiovascular and neurological medicine in Korean medicine Ⅰ", pp.117~133 (2016), Woori medical books
  33. Berman NG, "Meta-analysis : neither quick nor easy", BMC Med Res Methodol, 2(1), pp.10~ (2002)
  34. Kim YJ, "A survey on patients' compliance with follow-up coronary angiogram after coronary intervention", Korean J Adult Nurs, 12(1), pp.30~39 (2000)
  35. Wang Z, "Research progress of the molecular mechanism of Tongxinluo capsule treatment in cardio-cerebrovascular diseases", Chin J Emerg Med, 19(12), pp.2112~2114 (2010)
  36. Fan X, "Thirty-one cases of modified Gualou Xiebai Banxia decoction for treatment of the coronary heart disease with chronic heart failure with phlegm-turbid obstruction, qi stagnation and blood stasis type", Henan Tradit Chin Med, 32(09), pp.1122~1123 (2012)
  37. He Q, "Research on TCM syndromes and diagnosis of patients after percutaneous coronary intervention based on cluster analysis", J Tradit Chin Med, 10, pp.918~921 (2008)
  38. Lee CH, "Standards of medical care in percutaneous coronary intervention", Korean J Med, 83(2), pp.233~235 (2012)

관련 논문AI추천

경피적 관상동맥중재술 후 스텐트 내 재협착 예방에 대한 심적환의 효과 : 무작위배정 대조 임상연구에 대한 체계적 문헌고찰 및 메타분석강세영, 김락형, 김명호, 김홍준, 장인수, 허나연대한한방내과학회 · 대한한방내과학회지2025 · 제46권 제3호변이형 협심증 환자에 대한 한약병용치료의 효과 : 체계적 문헌고찰과 메타분석권성은, 권정남, 전현영대한한방내과학회 · 대한한방내과학회지2024 · 제45권 제6호경피적관상동맥중재술을 시행한 후 발생한 胸痛에 대한 한방치료 1례김예슬, 김학겸, 문지성, 민선우, 박지윤, 정지천대한한방내과학회 · 대한한방내과학회지2021 · 제42권 제2호심방세동의 심박수 조절 및 항응고인자에 대한 한약 치료 효과 : 체계적 문헌고찰 및 메타분석강세영, 김락형, 김명호, 서유민, 양창섭, 이기향, 장인수, 최유민대한한방내과학회 · 대한한방내과학회지2025 · 제46권 제3호관상동맥 중재술 후 문제점 및 삶의 질 개선에 관한 침 치료 효과 : 체계적 문헌 고찰권정남, 박의현, 이지성한의병리학회 · 동의생리병리학회지2019 · 제33권 제2호당뇨병성 말초혈관질환에 대한 보양환오탕(補陽還五湯)과 양약 병용요법의 효과 : 체계적 문헌고찰 및 메타분석김근모, 박소현, 배보람, 진명호대한한방내과학회 · 대한한방내과학회지2025 · 제46권 제6호

이 간행물의 다른 논문 (20건)

Yukgunja-tang for Irritable Bowel Syndrome: A Protocol for a Systematic Review and Meta-Analysis박재우, 고석재, 김민정, 박채현, 조민석, 이강욱pp. 285-293Ovalbumin으로 유발된 천식 동물모델에서 GGX의 효과김태현, 우성천, 김승형, 양원경, 이수원, 박양춘pp. 294-312심부전의 한약 임상연구에 활용된 한약재에 대한 기구축 DB(K-HERB NETWORK)를 활용한 네트워크 분석박수빈, 배기상, 김예지, 김철현, 윤인애, 추홍민, 임정태pp. 313-353제2형 당뇨병 환자에서 혈당강하제와 보중익기탕 병용 투여가 혈당 변화에 미치는 영향 및 안전성 연구송미령, 노지원, 안영민, 안세영, 이병철, 정우녕, 오승현pp. 354-365특발성 폐섬유증의 통합의료 협진 모델 개발을 위한 의료진 및 환자 대상 설문조사 연구최혜숙, 이범준, 신정원, 정희재, 진수현, 김관일, 양정민, 김수덕, 박지원pp. 366-386
원문 보기